Cargando…
Antifibrotic drugs for idiopathic pulmonary fibrosis: What we should know?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881818/ https://www.ncbi.nlm.nih.gov/pubmed/33107479 http://dx.doi.org/10.4103/ijmr.IJMR_90_20 |
| _version_ | 1783650956567642112 |
|---|---|
| author | Hadda, Vijay Guleria, Randeep |
| author_facet | Hadda, Vijay Guleria, Randeep |
| author_sort | Hadda, Vijay |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7881818 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78818182021-02-23 Antifibrotic drugs for idiopathic pulmonary fibrosis: What we should know? Hadda, Vijay Guleria, Randeep Indian J Med Res Editorial Wolters Kluwer - Medknow 2020-09 /pmc/articles/PMC7881818/ /pubmed/33107479 http://dx.doi.org/10.4103/ijmr.IJMR_90_20 Text en Copyright: © 2020 Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Editorial Hadda, Vijay Guleria, Randeep Antifibrotic drugs for idiopathic pulmonary fibrosis: What we should know? |
| title | Antifibrotic drugs for idiopathic pulmonary fibrosis: What we should know? |
| title_full | Antifibrotic drugs for idiopathic pulmonary fibrosis: What we should know? |
| title_fullStr | Antifibrotic drugs for idiopathic pulmonary fibrosis: What we should know? |
| title_full_unstemmed | Antifibrotic drugs for idiopathic pulmonary fibrosis: What we should know? |
| title_short | Antifibrotic drugs for idiopathic pulmonary fibrosis: What we should know? |
| title_sort | antifibrotic drugs for idiopathic pulmonary fibrosis: what we should know? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881818/ https://www.ncbi.nlm.nih.gov/pubmed/33107479 http://dx.doi.org/10.4103/ijmr.IJMR_90_20 |
| work_keys_str_mv | AT haddavijay antifibroticdrugsforidiopathicpulmonaryfibrosiswhatweshouldknow AT guleriarandeep antifibroticdrugsforidiopathicpulmonaryfibrosiswhatweshouldknow |